Publication of Notice of Annual General Meeting and Annual
Report
Dublin, London | 5 April 2024: Uniphar plc (the "Company" or "Uniphar") wishes to announce that it is
today posting to shareholders its Notice of Annual General Meeting
("AGM") for 2024 together
with its annual report and accounts for the year ended 31 December
2023 ("Annual Report"). The
AGM will be held at 11.00 a.m. on 9 May 2024 at the offices of
William Fry LLP, 2 Grand Canal Square, Dublin 2, D02
A342.
Uniphar values the participation of
its shareholders at its AGM and encourages all shareholders to take
part in the meeting either in person or by voting and raising
questions in advance.
The Notice of Meeting, Form of Proxy
and Annual Report are available to view on the Company's website
at https://www.uniphar.ie/static/investors/shareholder-centre/AGM/AGM-2024
and will be available for inspection during normal
business hours on any business day from today until the conclusion
of the AGM at the registered office of the Company.
Proxy voting can be carried out in
advance of the AGM. Details of how to do so are
set out in further detail in the Notice of Meeting.
A conference call facility will be
provided to allow shareholders to listen live to the business of
the AGM. Please note that you will not be able to use this facility
to vote, raise points or issues or ask questions. If you wish to
listen live to the AGM proceedings, you can register for the
conference call and receive participant log-in
details
at
https://www.uniphar.ie/static/investors/shareholder-centre/AGM/AGM-2024
Shareholders availing of this facility
should ensure to submit any votes in advance of the meeting as it
will not be possible to vote using the conference call
facility.
Shareholders are invited to submit
questions in writing in advance of the meeting either by email
to companysecretary@uniphar.ie
or by post to the Company
Secretary, Uniphar plc, 4045 Kingswood Road, Citywest Business
Park, Co. Dublin, D24 V06K, Ireland. Questions must be received by
11.00 a.m. on 7 May 2024. Shareholders must include their Shareholder Reference Number
(as set out on their Form of Proxy) with any question
submitted.
Contact details
|
Uniphar Group
|
Tel: +353 (0) 1 428
7777
|
|
Allan Smylie, Head of
Strategy and IR
|
|
|
|
Davy (Joint Corporate Broker, Nominated Advisor
and
Euronext Growth Listing Sponsor)
|
Tel: +353 (0) 1 679
6363
|
|
Daragh
O'Reilly
Niall
Gilchrist
Ivan Murphy
|
|
|
|
|
|
RBC Capital Markets (Joint Corporate
Broker)
|
Tel: +44 (0) 20 7653
4000
|
|
Jamil Miah
Rupert
Walford
|
|
|
|
|
|
Stifel Nicolaus Europe Limited (Joint
Corporate Broker)
|
Tel:
+44 (0) 20 7710 7600
|
|
Matt Blawat
Ben
Maddison
Francis
North
|
|
|
|
|
|
Q4 PR
|
Tel: +353 (0) 1 475
1444
|
|
Iarla Mongey, Public
Relations Advisor to Uniphar Group
|
|
About Uniphar plc
Headquartered in Dublin, Ireland,
the Uniphar Group is an international diversified healthcare
services business servicing the requirements of more than 200
multinational pharmaceutical and medical technology manufacturers
across three divisions - Uniphar Pharma, Uniphar Medtech and
Uniphar Supply Chain & Retail. The Group is active in Europe,
North America, APAC and MENA and delivers to 160+
countries.
The Company's vision is to improve
patient access to pharmaco-medical products and treatments by
enhancing connectivity between manufacturers and healthcare
stakeholders. Uniphar represents a strong combination of scale,
growth, and profitability.
Uniphar Supply Chain & Retail
Uniphar Supply Chain & Retail is
the leading pharmaceutical wholesaler in Ireland with a growing
symbol group offering of retail pharmacies. The Group's strategy
for Uniphar Supply Chain & Retail is to grow our wholesale
market share, our symbol group network and our own brand,
in-licenced and consumer products portfolio.
Uniphar Medtech
Uniphar Medtech is a leading
Pan-European medical device distributor and solutions partner. The
Group's strategy for Uniphar Medtech is to grow our service
offering across Europe and expand our addressable market by serving
new specialities and new manufacturers.
Uniphar Pharma
Uniphar Pharma operates a global
business with high value services across the lifecycle of a
pharmaceutical product. We enable pharma and biotech companies to
bring innovative medicines to global markets and provide healthcare
professionals with access to medicines they can't source through
traditional channels. Our strategy is to build a leading platform
to provide the specialist support and expertise needed to improve
access to these medicines.